Morocco Medical Cannabis Market Size, Share & Trends Analysis Report By Product (Flower, Oil & Tinctures), By Application (Chronic Pain, Tourette’s Syndrome, Cancer, Depression & Anxiety), And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation and Scope
                   1.2 Research Scope and Assumptions
                   1.3 Research Methodology
                   1.4 Research Methodology
                   1.5 Research Workflow
                   1.6 Information Procurement
                       1.6.1 Purchased Database
                       1.6.2 GVR’s Internal Database
                       1.6.3 Secondary sources:
                       1.6.4 Third-Party Perspective:
                       1.6.5 Primary Research
                   1.7 Information Analysis & Data Analysis Models
                       1.7.1 Market Formulation & Validation
                   1.8 List of Data Sources
Chapter 2 Executive Summary
                   2.1 Morocco Medical Cannabis Market Snapshot
                   2.2 Segment Snapshot
                   2.3 Competitive Landscape Snapshot
Chapter 3 Morocco Medical Cannabis Market Variables, Trends & Scope
                   3.1 Market Dynamics
                       3.1.1 Market Driver Analysis
                           3.1.1.1 Growing ADoption of Medical Marijuana for Treatment of Chronic Diseases
                           3.1.1.2 Elimination of Black Market Through Legalization
                           3.1.1.3 Growing Cannabis Tourism in the Country
                       3.1.2 Market Restraint Analysis
                           3.1.2.1 Lower Market Access of Marijuana Due to Absence of Legalization Programs
                           3.1.2.2 High Pricing of Medical Marijuana in Big & Established Markets
                           3.1.2.3 Legalization of Medical Cannabis for Selected Indications
                       3.1.3 Penetration and Growth Prospect Mapping
                   3.2 History of Medical Use of Cannabis
                   3.3 Morocco Medical Cannabis Market Analysis Tools
                       3.3.1 Morocco Medical Cannabis market - PESTLE Analysis
                           3.3.1.1 Political & Legal Landscape
                           3.3.1.2 Economic Landscape
                           3.3.1.3 Social Landscape
                           3.3.1.4 Technology Landscape
                       3.3.2 Morocco Medical Cannabis market - Porter’s Analysis
                       3.3.3 Supplier Power: Moderate
                       3.3.4 Buyer Power: Low
                       3.3.5 Substitution Threat: Moderate
                       3.3.6 Threat of New Entrants: Low
                       3.3.7 Competitive Rivalry: High
                   3.4 COVID-19 Impact on Morocco Medical Cannabis Market
                   3.5 Morocco Medical Cannabis Scenario and Insights
                       3.5.1 The Scale of the Moroccan Cannabis Industry
                       3.5.2 Cannabis Legalization and Cannabis Industry Future
                       3.5.3 Regulatory Scenario
                       3.5.4 Cannabis Illegal Trade Routes
                   3.6 Role of Cannabis License Holders and Their Relation with Farmers and Producers
                   3.7 Global Companies and Their Market Entry Strategies for the African Cannabis Industry
Chapter 4 Morocco Medical Cannabis Market: Product Estimates & Trend Analysis
                   4.1 Morocco Medical Cannabis Market: Product Movement Analysis, 2022 & 2030, USD Million
                   4.2 Flower
                       4.2.1 FLower market estimates and Forecasts, 2022 - 2030 (USD Million)
                   4.3 Oil and Tinctures
                       4.3.1 Oil and Tinctures market estimates and Forecasts, 2022 - 2030(USD Million)
Chapter 5 Morocco Medical Cannabis Analytics Market: Application Estimates & Trend Analysis
                   5.1 Morocco Medical Cannabis Market: Application Movement Analysis, 2022 & 2030, USD Million
                   5.2 Cancer
                       5.2.1 Cancer market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.2.2 Morocco Estimated cancer prevalence estimates and Forecasts, 2018 - 2030
                   5.3 Chronic Pain
                       5.3.1 Chronic pain market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.3.2 Morocco Estimated chronic pain prevalence estimates and Forecasts, 2018 - 2030 (Million)
                   5.4 Anxiety & Depression
                       5.4.1 Anxiety & depression market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.4.2 Morocco Estimated depressive disorders prevalence estimates and Forecasts, 2018 - 2030 (Million)
                   5.5 Arthritis
                       5.5.1 Arthritis market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.5.2 Morocco Estimated arthritis prevalence estimates and Forecasts, 2018 - 2030
                   5.6 Diabetes
                       5.6.1 Diabetes market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.6.2 Morocco Estimated diabetes mellitus prevalence estimates and Forecasts, 2018 - 2030 (Million)
                   5.7 Glaucoma
                       5.7.1 glaucoma market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.7.2 Morocco Estimated glaucoma prevalence estimates and Forecasts, 2018 - 2030
                   5.8 Migraines
                       5.8.1 Migraines market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.8.2 Morocco Estimated migraines prevalence estimates and Forecasts, 2018 - 2030 (Million)
                   5.9 Epilepsy
                       5.9.1 epilepsy market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.9.2 Morocco Estimated epilepsy prevalence estimates and Forecasts, 2018 - 2030
                   5.10 Multiple Sclerosis
                       5.10.1 Multiple sclerosis market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.10.2 Morocco Estimated multiple sclerosis prevalence estimates and Forecasts, 2018 - 2030
                   5.11 AIDS
                       5.11.1 AIDS market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.11.2 Morocco Estimated AIDS prevalence estimates and Forecasts, 2018 - 2030
                   5.12 Amyotrophic Lateral Sclerosis
                       5.12.1 Amyotrophic lateral sclerosis market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.12.2 Morocco Estimated motor neuron disease prevalence estimates and Forecasts, 2018 - 2030
                   5.13 Alzheimer’s
                       5.13.1 Alzheimer’s market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.13.2 Morocco Estimated ALzheimer’s and dementia prevalence estimates and Forecasts, 2018 - 2030
                   5.14 Post-Traumatic Stress Disorder (PTSD)
                       5.14.1 PTSD market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.14.2 Morocco Estimated PTSD prevalence estimates and Forecasts, 2018 - 2030 (Million)
                   5.15 Parkinson’s
                       5.15.1 Parkinson’s market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.15.2 Morocco Estimated Parkinson’s prevalence estimates and Forecasts, 2018 - 2030
                   5.16 Tourette’s
                       5.16.1 Tourette’s market estimates and Forecasts, 2022 - 2030 (USD Million)
                       5.16.2 Morocco Estimated Tourette’s prevalence estimates and Forecasts, 2018 - 2030
                   5.17 Others
                       5.17.1 others market estimates and Forecasts, 2022 - 2030 (USD Million)
Chapter 6 Competitive Landscape and Analysis
                   6.1 Company Profiles
                       6.1.1 Participant’s overview
                       6.1.2 Product Benchmarking
                       6.1.3 Strategic Initiatives
                       6.1.4 COMPANY MARKET POSITION ANALYSIS
                   6.2 List of other companies

List of Tables

Table 1 List of secondary sources
Table 2 Morocco medical cannabis market, by type, 2022 - 2030 (USD Million)
Table 3 Morocco medical cannabis market, by application, 2022 - 2030 (USD Million)

List of Figures

Fig. 1 Morocco medical cannabis market segmentation
Fig. 2 Estimation Methodology
Fig. 3 Various stages of the research workflow
Fig. 4 Information procurement
Fig. 5 Primary research pattern
Fig. 6 Market Formulation & Validation
Fig. 7 Morocco medical cannabis market summary, 2022 (USD Million)
Fig. 8 Morocco medical cannabis market: Segment Summary, 2022 (USD Million)
Fig. 9 Morocco medical cannabis market: Competitive Landscape (USD Million)
Fig. 10 Penetration & growth prospect mapping for the product segment, 2022
Fig. 11 History of industrial and medical use of cannabis in Morocco
Fig. 12 History of industrial and medical use of cannabis in Morocco
Fig. 13 Morocco medical cannabis market: Product outlook key takeaways, USD Million
Fig. 14 Morocco medical cannabis market: Product movement analysis, 2022 & 2030
Fig. 15 Flower market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 16 Oil and tinctures market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 17 Morocco medical cannabis market, Application outlook key takeaways, USD Million
Fig. 18 Morocco medical cannabis market: Application movement analysis, 2022 & 2030 (USD Million)
Fig. 19 Cancer market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 20 Morocco estimated cancer prevalence estimates and forecasts, 2018 - 2030
Fig. 21 Chronic pain market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 22 Morocco estimated chronic pain prevalence estimates and forecasts, 2018 - 2030 (Million)
Fig. 23 Anxiety & depression market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 24 Morocco estimated depressive disorders prevalence estimates and forecasts, 2018 - 2030 (Million)
Fig. 25 Arthritis market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 26 Morocco estimated arthritis prevalence estimates and forecasts, 2018 - 2030
Fig. 27 Diabetes market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 28 Morocco estimated diabetes mellitus prevalence estimates and forecasts, 2018 - 2030 (Million)
Fig. 29 Glaucoma market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 30 Morocco estimated glaucoma prevalence estimates and forecasts, 2018 - 2030
Fig. 31 Migraines market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 32 Morocco estimated migraines prevalence estimates and forecasts, 2018 - 2030 (Million)
Fig. 33 Epilepsy market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 34 Morocco estimated epilepsy prevalence estimates and forecasts, 2018 - 2030
Fig. 35 Multiple sclerosis market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 36 Morocco estimated multiple sclerosis prevalence estimates and forecasts, 2018 - 2030
Fig. 37 AIDS market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 38 Morocco estimated AIDS prevalence estimates and forecasts, 2018 - 2030
Fig. 39 Amyotrophic lateral sclerosis market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 40 Morocco estimated motor neuron disease prevalence estimates and forecasts, 2018 - 2030
Fig. 41 Alzheimer’s market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 42 Morocco estimated Alzheimer’s and dementia prevalence estimates and forecasts, 2018 - 2030
Fig. 43 PTSD market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 44 Morocco estimated PTSD prevalence estimates and forecasts, 2018 - 2030 (Million)
Fig. 45 Parkinson’s market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 46 Morocco estimated Parkinson’s prevalence estimates and forecasts, 2018 - 2030
Fig. 47 Tourette’s market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 48 Morocco estimated Tourette’s prevalence estimates and forecasts, 2018 - 2030
Fig. 49 Others market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 50 Company market position analysis